generics

Fresenius Lifts Outlook again on Rivals' Shortages

China Changes Patent Law in Fight for Cheaper Drugs

Drugmakers Slam "Punitive" German Pricing Measures

Espicom Predicts Growth of Global Generic Drug Markets

Merck KGaA, Dr. Reddy's in Biosimilars Deal

Teva Chairman Buys 1 Million Shares of Drugmaker

Stada to Seek Deals as Sector Consolidates

GSK Partner Pronova Wins Fish Oil Drug Patent Fight

Teva Cuts Profit View on Weak European Markets

Bridgepoint to Sell Drugs Maker Aenova

EU Adviser Backs Antitrust Fine for AstraZeneca

Teva Profit Beats Forecasts on US Drug Sales

FDA Says Number of New U.S. Drug Shortages Down

Cardinal Q3: Pharmaceutical Unit Strong

Watson Profit Tops Wall Street Estimate

Warner Chilcott to Explore Sale of Company

Sanofi Strong in Emerging Markets as Rivals Flag

EU Plans to Block Fake Drugs Spark Industry Row

New J&J CEO Parachuting Into Tough Terrain

US FTC Loses Bid to Block Pay-for-delay Drug Deals

Amgen to Buy Turkish Drugmaker for $700 mln

Watson, Actavis to Unveil Deal

US Top Court Rules for Generic Drugmaker on Patent

Biosimilar Remicade Accepted for EU Drug Review

Watson, Actavis Aim for Deal

U.S. Medicine Spending Rose to $320 Billion Last Year

Teva Launches Generic High Blood Pressure Drugs

US Court Finds Astra Seroquel XR Patent Infringed

AstraZeneca Settles US Seroquel Xr Patent Infringement Litigation With Handa

Trial Set For Teva-Mylan Copaxone Lawsuit

Hungary Government Raises Sales Tax, Fees On Drug Firms

Amylin Sues Lilly over Diabetes Partnership

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva to buy 57% of Taiyo for $460 Million

Topics • Technology

Porsche Consulting on Lessons from the Auto Industry

22 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

F. Hoffmann-La Roche Ltd

Porsche Consulting

Camelot Management Consultants AG

Fitch Ratings

Saltigo GmbH

SchüllerConsulting

Arthur D. Little

CMS Advisors GmbH & Co. KG

Thomson Reuters

Deutsche Post DHL

ARC Advisory Group GmbH & Co KG

Camelot Management Consultants AG

Enigma Marketing Research